Cited by

• PSMA PET for the Evaluation of Liver Metastases in Castration-Resistant Prostate Cancer Patients: A Multicenter Retrospective Study.

  Mattoni S, Farolfi A, Formaggio F, Bruno G, Caroli P, Cerci JJ, Eiber M, Fendler WP, Golfieri R, Herrmann K, Matteucci F, Mosconi C, Paolani G, Santoro M, Strigari L, Nanni C, Castellucci P, Fanti S. Mattoni S, et al. Cancers (Basel). 2022 Nov 18;14(22):5680. doi: 10.3390/cancers14225680. Cancers (Basel). 2022. PMID: 36428771 Free PMC article.
• PSMA Radioligand Uptake as a Biomarker of Neoangiogenesis in Solid Tumours: Diagnostic or Theragnostic Factor?

  Rizzo A, Dall'Armellina S, Pizzuto DA, Perotti G, Zagaria L, Lanni V, Treglia G, Racca M, Annunziata S. Rizzo A, et al. Cancers (Basel). 2022 Aug 21;14(16):4039. doi: 10.3390/cancers14164039. Cancers (Basel). 2022. PMID: 36011032 Free PMC article. Review.
• PSMA-based ¹⁸F-DCFPyL PET: a better choice than multiparametric MRI for prostate cancer diagnosis?

  Zhang X, Son MH, Ha LN, Lan X. Zhang X, et al. Am J Nucl Med Mol Imaging. 2022 Dec 15;12(6):195-200. eCollection 2022. Am J Nucl Med Mol Imaging. 2022. PMID: 36636231 Free PMC article.
• The Value of Multimodality PET/CT Imaging in Detecting Prostate Cancer Biochemical Recurrence.

  Jiang J, Tang X, Pu Y, Yang Y, Yang C, Yang F, Tian Y, Li J, Sun H, Zhao S, Chen L. Jiang J, et al. Front Endocrinol (Lausanne). 2022 May 27;13:897513. doi: 10.3389/fendo.2022.897513. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35712249 Free PMC article. Review.
• ⁶⁸Ga-PSMA PET/CT-Based Atlas for Prostate Bed Recurrence After Radical Prostatectomy: Clinical Implications for Salvage Radiation Therapy Contouring Guidelines.

  Sonni I, Dal Pra A, O'Connell DP, Ells Z, Benz M, Nguyen K, Yoon SM, Deng J, Smith C, Grogan T, Nickols NG, Cao M, Kishan AU, Calais J. Sonni I, et al. J Nucl Med. 2023 Jun;64(6):902-909. doi: 10.2967/jnumed.122.265025. Epub 2023 Feb 9. J Nucl Med. 2023. PMID: 36759200 Free PMC article.